The Senate Finance Committee released a report in 2015 which revealed that the hepatitis C drug ‘Solvadi’ was being priced and marketed to maximize profits for a pharmaceutical company, and was at the expense of consumers. In response to this report, Klobuchar called on Congress to act immediately to pass legislation to lower prescription drug prices for consumers.
“It is as clear as ever: we have an urgent problem with the cost of prescription drugs in our country. This report presents yet another example in which a drug manufacturer’s first priority is how much money it can squeeze from consumers with no regard for what it means for the Americans who need its treatment. This is an alarming trend that we cannot allow to continue. We need to pass legislation to protect consumers from the unjustified inflation of prescription drug prices.”
In Light of New Report on Profit-Driven Prescription Drug Pricing, Klobuchar Continues Call for Congress to Immediately Pass Her Legislation to Lower Drug Prices for Consumers
Amy Klobuchar senate website, December 1, 2015
Read More
In Light of New Report on Profit-Driven Prescription Drug Pricing, Klobuchar Continues Call for Congress to Immediately Pass Her Legislation to Lower Drug Prices for Consumers
Amy Klobuchar senate website, December 1, 2015
